ATEC - Alphatec Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.82
-0.08 (-1.36%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close5.90
Open5.90
Bid5.66 x 2900
Ask7.72 x 800
Day's Range5.79 - 6.00
52 Week Range1.18 - 6.35
Volume472,951
Avg. Volume463,270
Market Cap348.797M
Beta (3Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire

    Alphatec Accelerates Organic Innovation Machine™ With  Key Senior Leadership Appointment and Continued Sales Team Enhancements

    •  Eric Dasso to Lead Revolutionary Alpha InformatiX™ Platform•  Wyatt Stanfield to Drive Western US Sales Expansion CARLSBAD, Calif., Aug. 15, 2019 -- Alphatec Holdings, Inc..

  • GlobeNewswire

    Alphatec Advances InVictus™ MIS Spinal Fixation System With Commercial Launch of SingleStep™

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus Minimally Invasive, or MIS, SingleStep K-wireless implant delivery system. SingleStep utilizes an all-in-one driver designed to enhance surgical efficiency without compromising accuracy. “This release enhances the functionality and distinction of ATEC’s newly-launched InVictus platform with technology that has been engineered to profoundly improve the elegance of percutaneous fixation,” said Pat Miles, Chairman and Chief Executive Officer.  “SingleStep enables increased surgeon control of the variables surrounding percutaneous pedicle screw placement.

  • GlobeNewswire

    Alphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

    Alphatec Holdings, Inc. (“ATEC”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 12,535,000 shares of its common stock at a public offering price of $4.60 per share, which includes the full exercise of the underwriters’ option to purchase 1,635,000 additional shares of common stock to cover over-allotments. Piper Jaffray and Canaccord Genuity acted as joint book-running managers in the offering. Lake Street Capital Markets acted as co-manager in the offering.

  • GlobeNewswire

    Alphatec to Present at the Canaccord Genuity 39th Annual Growth Conference

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it will attend the 39th Annual Growth Conference taking place at the InterContinental Hotel in Boston.  Pat Miles, Chairman and CEO, will present a business overview at the conference on August 7, 2019, at 5:00 P.M. ET. A live audio webcast of the conference presentation, along with a copy of the accompanying presentation materials, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com. Alphatec Holdings, Inc., through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery.

  • GlobeNewswire

    Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock

    Alphatec Holdings, Inc. (“ATEC”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of an underwritten public offering of 10,900,000 shares of its common stock at a public offering price of $4.60 per share.  The offering is expected to close on or about August 2, 2019, subject to the satisfaction of customary closing conditions. In connection with the offering, ATEC has granted the underwriters a 30-day option to purchase up to an additional 1,635,000 shares of common stock in the offering at the public offering price, less underwriting discounts and commissions.

  • GlobeNewswire

    Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock

    Alphatec Holdings, Inc. (“ATEC”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, ATEC intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering. Piper Jaffray and Canaccord Genuity are acting as joint book-running managers in the offering.

  • GlobeNewswire

    Alphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights

    Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth  CARLSBAD, Calif., July 24, 2019 -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq:.

  • GlobeNewswire

    Alphatec Announces Commercial Launch of the InVictus™ MIS and Open Spinal Fixation Systems

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus™, a comprehensive spinal fixation platform designed to address a range of pathologies through a minimally invasive (MIS), open, or hybrid surgical approach. With the introduction of the InVictus systems, ATEC has launched seven of twelve products planned for 2019.

  • GlobeNewswire

    Alphatec Announces Commercial Launch of ALIF IdentiTi™ Porous Titanium Interbody System Implant

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi Large Window Porous Titanium Interbody Implant System for anterior lumbar interbody fusion (ALIF) procedures.

  • GlobeNewswire

    Alphatec to Report Second Quarter 2019 Financial Results on July 24, 2019

    CARLSBAD, Calif., July 11, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to.

  • GlobeNewswire

    Alphatec Announces Organizational and Corporate Updates

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the appointment of Karen McGinnis to its Board of Directors.  The Company also announced that it is joining the Russell 2000® Index and that it made a drawdown of $10 million under its expanded secured financing facility with Squadron Medical Finance Solutions, LLC (“Squadron”).

  • GlobeNewswire

    Alphatec Announces Updated Presentation Date and Time at the Raymond James Life Sciences and MedTech Conference

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that Jeff Black, Executive Vice President and Chief Financial Officer, will present at the Raymond James Life Sciences and MedTech Conference on June 18, 2019, at 4:10 P.M. ET at the Lotte New York Palace in New York, NY. A live audio webcast of the conference presentation, along with copies of the accompanying presentation material, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com.

  • GlobeNewswire

    Alphatec Announces Commercial Launch of TLIF IdentiTi™ Posterior Curved Porous Titanium Interbody Implant System

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi-PC Porous Titanium Interbody Implant System for Transforaminal Lumbar Interbody Fusion Procedures (TLIF). The porosity creates a roughness that improves initial stability through surface adhesion and facilitates bone apposition,” remarked Geoffrey Cronen, MD, of Florida Medical Clinic Orthopaedic Surgery.

  • GlobeNewswire

    Alphatec to Participate in the Jefferies 2019 Global Healthcare Conference and the Raymond James Life Sciences and MedTech Conference

    Pat Miles, ATEC’s Chairman and CEO, will present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019, at 8:00 A.M. ET. Live audio webcasts of each of the conference presentations, along with copies of the accompanying presentation materials, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com.

  • GlobeNewswire

    Alphatec to Present at the 20th Annual B. Riley FBR Investor Conference

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it will attend the 20th Annual B. Riley FBR Investor Conference at the Beverly Hilton Hotel in Los Angeles, California. A live audio webcast of the conference presentation, along with a copy of the accompanying presentation materials, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com.

  • GlobeNewswire

    Alphatec Reports First Quarter 2019 Financial Results and Corporate Highlights

    CARLSBAD, Calif., May 09, 2019 -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to.

  • GlobeNewswire

    Alphatec to Report First Quarter 2019 Financial Results on May 9, 2019

    CARLSBAD, Calif., April 18, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to.

  • GlobeNewswire

    Alphatec Announces Sales Leadership Appointment And Successful Closing of Expanded Credit Facility With Squadron Capital

    Alphatec Holdings, Inc.  (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the promotion of David Sponsel into the role of Executive Vice President, Sales. The Company also announced the closing of its expanded $30 million secured financing facility with Squadron Medical Finance Solutions, LLC. Sponsel joined ATEC in May 2018 as Area Vice President, West.

  • GlobeNewswire

    Alphatec Announces Commercial Launch of its First IdentiTi™ Porous Titanium Interbody System

    It marks the first of six IdentiTi implant systems the Company expects to commercially introduce in 2019. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

  • GlobeNewswire

    Alphatec Announces Participation At Canaccord and Cowen Investor Conferences in March

    ATEC will present at the Cowen 39th Annual Healthcare conference, located at the Boston Marriott Copley Place in Boston.  The Company’s live presentation is scheduled for Monday, March 11 at 11:20 a.m. A copy of the presentation will be available online from the investor relations page of the Company's corporate website at www.atecspine.com.

  • GlobeNewswire

    Alphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results

    CARLSBAD, Calif., March 07, 2019 -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results and operating highlights for the fourth.

  • ACCESSWIRE

    Alphatec Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 7, 2019 / Alphatec Holdings, Inc. (NASDAQ: ATEC ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 7, 2019 at 4:30 PM ...

  • GlobeNewswire

    Alphatec Announces FDA Clearance of its Automated SafeOp Neuromonitoring System to Address Significant Unmet Needs in Spine Surgery

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC) announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its automated SafeOp neuromonitoring system for use in real-time intraoperative nerve location and health assessment. “I could not be more excited to integrate this revolutionary technology into our growing number of spine approaches,” said Pat Miles, Chairman and Chief Executive Officer. The next-generation technology of the SafeOp system represents a significant advancement in two intraoperative neurophysiological monitoring (IONM) modalities: somatosensory evoked potential (SSEP), and electromyography (EMG).  SSEP assesses the functional health of the spinal cord and nerves, while EMG enables surgeons to test nerves for their location, proximity, and conduction.  The SafeOp automated SSEP technology has been successfully used in more than 1,000 surgeries to identify potential nerve injury from patient positioning, and has demonstrated reliability in monitoring peripheral nerves in spine surgery.

  • GlobeNewswire

    Alphatec to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7, 2019

    CARLSBAD, Calif., Feb. 21, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”) announced today that the Company plans to release its fourth quarter and.